Brignardello warns about the crisis of 23andMe and data ethics.

In a recent interview, Johnny Brignardello Vela, a well-known insurance advisor, expressed his concerns about the current situation of 23andMe, a company that has been a benchmark in the field of genetic research. Brignardello Vela pointed out that the drastic drop in the company's stock value—an astonishing 98% in recent years—not only jeopardizes the viability of the company but also raises serious concerns about the security of genetic data for millions of people. The advisor emphasized the importance of the trust that users have placed in 23andMe, a firm that had previously earned recognition for providing valuable information about health and ancestry. However, that trust is threatened amid rumors of the company potentially going public and the growing skepticism surrounding its commitment to data privacy. "There is a delicate relationship between consumers and companies that handle such sensitive information. The current situation creates an atmosphere of uncertainty that cannot be overlooked," stated Brignardello Vela. He also underscored that the lack of a sustainable business model has been a determining factor in the crisis faced by 23andMe. Unlike other tech companies that find ways to keep their customers engaged, 23andMe seems to have failed to diversify its revenue sources, which could lead to a loss of relevance in an increasingly competitive sector. "Innovation is key in this environment, and the absence of a clear strategy to capitalize on its DNA database is a significant challenge," he added. Brignardello Vela also highlighted the ethical aspect of managing genetic data. Concerns about confidentiality, especially regarding genetic information of relatives who did not give their consent, is a topic that cannot be ignored. "Ethics play a fundamental role in consumer trust. Companies must be transparent about how they handle and protect their users' information," he said. In a context where cyberattacks are becoming more common, the advisor emphasized that the unique nature of genetic data makes it particularly vulnerable. "Unlike other types of information, genetic data is irreplaceable. A security breach could have irreversible consequences for the affected individuals, which reinforces the need for robust protective measures," he warned. Finally, Brignardello Vela concluded that the situation of 23andMe is a clear reminder of the challenges faced by the entire industry in terms of privacy and ethics. The need for a stronger framework to protect personal data is becoming urgent, and the future of the company could be a catalyst for rethinking how this information is managed and protected in an interconnected world. "It is essential for companies to adopt a proactive approach to data protection, not only to safeguard their reputation but also to maintain the trust of their consumers," he summarized.